81919-14-4
81919-14-4
Chemical Structure
Bendazac L-Lysine
- CAS No.: 81919-14-4
- Formula:C22H28N4O5
- Molecular Weight:428.48
IUPAC Name: L-lysine compound with 2-((1-benzyl-1H-indazol-3-yl)oxy)acetic acid (1:1)
InChIKey: OCOCFNMFLNFNIA-ZSCHJXSPSA-N
SMILES: O=C(O)COC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3.N[C@@H](CCCCN)C(O)=O
Biological Activity: Bendazac L-Lysine is one of agents that have been introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bendazac L-Lysine | 99.35% | Bendazac L-Lysine is one of agents that have been introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bendazac L-Lysine (Standard) | ≥98% | Bendazac L-Lysine (Standard) is the analytical standard of Bendazac L-Lysine. This product is intended for research and analytical applications. Bendazac L-Lysine is one of agents that have been introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
